MeVis Medical Solutions AG (M3V):企業の財務・戦略的SWOT分析

◆英語タイトル:MeVis Medical Solutions AG (M3V) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME40437FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

MeVis Medical Solutions AG (M3V) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

MeVis Medical Solutions AG (MMS AG), a subsidiary of Varex Imaging Corp, is a medical technology company. It develops and markets software to analyze and evaluate image data to medical device equipment manufacturers and providers of medical IT platforms. The company’s software solutions are used in screening, diagnostics, therapy and intervention planning for breast, lung, colon, and prostate cancers; and neurological disorders. Its solutions portfolio includes industrial solutions; and professional solutions such as MeVis Distant services, MeVis online academy and Veolity. The company operates its Digital Mammography business through joint venture, MeVis BreastCare GmbH & Co. KG. MMS AG is headquartered in Bremen, Germany.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
MeVis Medical Solutions AG – Key Facts
MeVis Medical Solutions AG – Key Employees
MeVis Medical Solutions AG – Key Employee Biographies
MeVis Medical Solutions AG – Major Products and Services
MeVis Medical Solutions AG – History
MeVis Medical Solutions AG – Company Statement
MeVis Medical Solutions AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
MeVis Medical Solutions AG – Business Description
Product Category: Maintenance Revenues
Performance
Product Category: Proceeds from the Sale of Licenses
Performance
Product Category: Rest
Performance
R&D Overview
MeVis Medical Solutions AG – SWOT Analysis
SWOT Analysis – Overview
MeVis Medical Solutions AG – Strengths
MeVis Medical Solutions AG – Weaknesses
MeVis Medical Solutions AG – Opportunities
MeVis Medical Solutions AG – Threats
MeVis Medical Solutions AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
MeVis Medical Solutions AG, Medical Equipment, Deals By Year, 2015 to YTD 2021
MeVis Medical Solutions AG, Medical Equipment, Deals By Type, 2015 to YTD 2021
MeVis Medical Solutions AG, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
MeVis Medical Solutions AG, Key Facts
MeVis Medical Solutions AG, Key Employees
MeVis Medical Solutions AG, Key Employee Biographies
MeVis Medical Solutions AG, Major Products and Services
MeVis Medical Solutions AG, History
MeVis Medical Solutions AG, Joint Venture
MeVis Medical Solutions AG, Key Competitors
MeVis Medical Solutions AG, Ratios based on current share price
MeVis Medical Solutions AG, Annual Ratios
MeVis Medical Solutions AG, Annual Ratios (Cont...1)
MeVis Medical Solutions AG, Annual Ratios (Cont...2)
MeVis Medical Solutions AG, Interim Ratios
MeVis Medical Solutions AG, Medical Equipment, Deals By Year, 2015 to YTD 2021
MeVis Medical Solutions AG, Medical Equipment, Deals By Type, 2015 to YTD 2021
MeVis Medical Solutions AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[MeVis Medical Solutions AG (M3V):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CEL-SCI Corp (CVM)-製薬・医療分野:企業M&A・提携分析
    Summary CEL-SCI Corp (CEL-SCI) is a biotechnology company that carries out the research and development of new immunotherapy products for the treatment of various cancer and infectious diseases. Its core capabilities include drug discovery, research, development and manufacturing of compound biologi …
  • NaviNet Inc:企業の戦略的SWOT分析
    NaviNet Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Caverion Corp:企業の戦略・SWOT・財務情報
    Caverion Corp - Strategy, SWOT and Corporate Finance Report Summary Caverion Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • MacroGenics Inc (MGNX):企業の財務・戦略的SWOT分析
    MacroGenics Inc (MGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • ACEA Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary ACEA Biosciences Inc (ACEA) is a biotechnology company that concentrates on the development and commercialization of innovative cell analysis instrumentation for life science research and clinical diagnostics. The company's products include impedance-based, label-free, and real-time cell ana …
  • EZCORP Inc (EZPW):企業の財務・戦略的SWOT分析
    EZCORP Inc (EZPW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Axcelis Technologies Inc (ACLS):企業の財務・戦略的SWOT分析
    Summary Axcelis Technologies Inc (Axcelis) operates as a technology company that provides industrial equipment and services for semiconductor industries. The company’s offers ion implantation product, which include high current implanters, purion H, optima HDx, high energy purion XE, optima XEx, par …
  • The Broad Institute Inc-医療機器分野:企業M&A・提携分析
    Summary The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation is a non-profit research organization that conducts genomic research for treatment of human diseases. The organization transforms medicine by utilizing systematic approaches in biological sciences, to speed up th …
  • Calavo Growers, Inc. (CVGW):企業の財務・戦略的SWOT分析
    Calavo Growers, Inc. (CVGW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Microbot Medical Inc (MBOT):製薬・医療:M&Aディール及び事業提携情報
    Summary Microbot Medical Inc (Microbot), formerly StemCells Inc, a subsidiary of Stem Cell Sciences UK Ltd, is a medical device company that develops pharmaceutical, cell based therapeutics and related tools. The company provides research on products for spinal cord injury, thoracic injury, cervical …
  • Medigard Ltd (MGZ)-医療機器分野:企業M&A・提携分析
    Summary Medigard Ltd (Medigard), formerly Medisafe Instruments Pty Ltd is a medical device company that designs and develops retractable safety medical devices. The company offers products such as auto-retractable syringe, manual retractable syringe, blood collection device, intravenous valve and fl …
  • Assore Limited:企業の戦略・SWOT・財務情報
    Assore Limited - Strategy, SWOT and Corporate Finance Report Summary Assore Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Allianz France S.A.:企業の戦略・SWOT・財務分析
    Allianz France S.A. - Strategy, SWOT and Corporate Finance Report Summary Allianz France S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Las Vegas Sands Corp:企業の戦略・SWOT・財務情報
    Las Vegas Sands Corp - Strategy, SWOT and Corporate Finance Report Summary Las Vegas Sands Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Makita Corporation (6586):企業の財務・戦略的SWOT分析
    Makita Corporation (6586) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Audentes Therapeutics Inc (BOLD):企業の財務・戦略的SWOT分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myopathy; AT982, for the treatmen …
  • ConocoPhillips (COP)-エネルギー分野:企業M&A・提携分析
    Summary ConocoPhillips is an independent upstream oil and gas company. The company explore for, produce, transport and market crude oil, bitumen, natural gas, liquefied natural gas (LNG) and natural gas liquids across the world. It has assets across North America, Europe, Asia and Australia. Its ass …
  • Amgen Inc (AMGN):企業の財務・戦略的SWOT分析
    Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ilmarinen Mutual Pension Insurance Co-エネルギー分野:企業M&A・提携分析
    Summary Ilmarinen Mutual Pension Insurance Company (IMPIC) is a financial service provider that offers pension insurance and related services. The company provides services for private customers, which include information on pensions, retiring, pensioner, forms and brochures, pensioner's tax card, a …
  • AcelRx Pharmaceuticals Inc (ACRX):製薬・医療:M&Aディール及び事業提携情報
    Summary AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain. The company’s lead product candidate, Dsuvia (known as Dzuveo outside the US), is a single sufentanil sublingual tablet for the treatment of moderate-t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆